The Standing Vaccination Commission recommends Astrazeneca vaccinations in Germany only for people over 60 years of age.
Virologist Hendrik Streeck is astonished at the recommendation for a second vaccination.
On Wednesday (April 7th) the EMA unreservedly recommended the use of the corona vaccine from Astrazeneca *.
Stiko is sticking to its recommendation to only use Astrazeneca in the fight against the coronavirus * for people over 60.
Virologist Hendrik Streeck is surprised at the Stiko recommendation for a second vaccination for people who have already received a first Astrazeneca vaccination.
This news ticker is updated regularly.
Update from April 9, 8:41 p.m.: So
far, 42 suspected cases of sinus vein thrombosis after vaccination with the corona vaccine from Astrazeneca are known in Germany.
The Paul Ehrlich Institute reported on Friday evening.
The 42 cases of the special form of very rare cerebral vein thrombosis had been reported by April 2, in 23 cases thrombocytopenia (lack of blood platelets) had also been registered.
With the exception of seven cases, women between the ages of 20 and 63 were affected.
However, according to the Robert Koch Institute, women were vaccinated with the product more often than men.
The men were 24 to 58 years old.
Eight victims died, five women and three men, as the institute responsible for vaccine safety in Langen reported.
For women between 20 and 59 years, significantly more cases were observed than was expected.
The vaccine is now generally only used in Germany for people aged 60 and over.
Seven cases of sinus vein thrombosis were reported after vaccination with the Biontech vaccine, three women aged 34 to 81 years and four men aged 81 to 86 years were affected.
In no case was thrombocytopenia reported.
However, taking into account the inoculated doses, the number of reported cases is not increased compared to the usually expected number of these thromboses.
By April 2, a total of around 14.38 million vaccinations had been carried out in Germany.
407 deaths were reported to the institute “at different intervals from vaccination” in people between the ages of 24 and 102 years.
The interval was between less than an hour and 40 days.
The overwhelming majority had multiple previous illnesses, which were presumably the cause of death.
Further information was requested in individual suspected cases.
Astrazeneca vaccinations: EMA is now also examining connection with Clarkson syndrome
Update from April 9, 4:21 p.m.:
The EU Medicines Agency EMA is investigating a possible connection between the Astrazeneca vaccine and capillary leak syndrome.
It is about five cases of the vascular disease also known as Clarkson syndrome.
In this condition, which occurs only very rarely, the permeability of the capillary vessels is too high, so that plasma escapes and edema and a drop in blood pressure occur.
It was only on Wednesday (April 7) that the EU authorities dealt with a possible connection between the Astrazeneca vaccination and dozen, sometimes fatal, cases of thrombosis.
She concluded that the benefit of the vaccination outweighed the risk and only recommended that blood clots be listed as a "very rare side effect" of the vaccine in the future.
In Germany, the use of the Astrazeneca vaccine has been restricted to people aged 60 and over.
Astrazeneca: Minister of Economic Affairs Altmaier vaccinated with corona vaccine
Update from April 9, 10:32 a.m.:
Federal Minister of Economics Peter Altmaier (CDU) has been vaccinated against the corona virus with the Astrazeneca vaccine.
The 62-year-old received his first dose in Berlin on Friday, his ministry said.
Altmaier said that he received the vaccination “regularly”.
"Vaccination is the crucial step in overcoming this pandemic," continued the minister.
He appealed to the citizens of the country to use this opportunity as well.
Astrazeneca vaccination in Germany: Streeck surprised at the new Stiko recommendation
First report from April 8, 2021:
Amsterdam - "The benefits of the active ingredient in combating Covid-19 are significantly higher than the risks," said Emer Cooke, Director of the European Medicines Agency (EMA), at a press conference in Amsterdam on Wednesday.
The EMA experts found a link between Astrazeneca vaccinations and blood clots when there were very low numbers of platelets at the same time.
However, this occurs very rarely.
Therefore, the authority decided to continue to recommend the Astrazeneca vaccine unreservedly.
Astrazeneca: Stiko remains with the recommendation for over 60-year-olds - Germany has alternatives
The Standing Vaccination Commission (Stiko) is sticking to its recommendation that the Astrazeneca vaccine in Germany only be used in people over 60 years of age, despite the positive opinion from the EMA.
The chairman Thomas Mertens announced on Thursday on
ZDF
- "Morgenmagazin".
If you look at all of Europe, the EMA is definitely right with its positive assessment of the Astrazeneca vaccination, emphasized Mertens on the
RBB
-Inforadio: "Because there are many countries in Europe that are almost completely dependent on Astrazeneca for their vaccination campaign." In Germany if it were different, other preparations would also be available.
“We have the option of postponing vaccines to different age groups, thereby reducing or even eliminating the risk of serious side effects,” said Mertens.
+
Stiko sticks to its recommendation to use Astrazeneca's corona vaccine for people over 60.
(Symbol image)
© Matthias Bein / dpa
"We are sticking to the fact that we follow the recommendations of the Standing Vaccination Commission," said Federal Health Minister Jens Spahn (CDU) on Thursday in
WDR5
- "Morning Echo".
He agreed with Merten's argument that alternative corona vaccines * were available in Germany and could therefore stick to the recommendation out of caution.
"If we only had Astrazeneca as a vaccine and no alternative for the under 60-year-olds, then one might come to a different conclusion when considering - what is the recommendation," said Spahn.
Astrazeneca: Stiko recommends a second vaccination with another corona vaccine
The reactions to the EMA assessment of the Astrazeneca vaccine have so far been different in European countries.
Italy and Spain changed their vaccination guidelines and recommend Astrazeneca's preparation, like Germany, only for people over 60 years of age.
In Austria, however, the national vaccination committee was in favor of following the EMA recommendation and continuing to recommend the Astrazeneca vaccine without reservation.
Younger people who have already received a first vaccination with the Astrazeneca vaccine, the Stiko, which is based at the Robert Koch Institute (RKI) *, recommends a second vaccination with another corona vaccine, from Biontech * or Moderna * .
“Many believe that two vaccines will then work in competition in the body,” explained Mertens, “but that's not the case.” Rather, the actual vaccine quickly disappeared from the body.
“What remains is the immune response,” said the Stiko chairman on
ZDF
- “Morgenmagazin”.
In a conversation with the
Rheinische Post
, Mertens put forward the thesis that a second vaccination with another corona vaccine * could even lead to a better protective effect.
Astrazeneca second vaccination: Streeck surprised at Stiko recommendation
The virologist Hendrik Streeck was surprised at the Stiko recommendation to offer Astrazeneca first vaccinated people a second vaccination with another vaccine.
“The clinical studies have not yet run.
I think it is necessary to stick to the rules and wait to see whether the studies are successful, ”Streeck told the
Fuldaer Zeitung
.
However, he considers the decision not to vaccinate the Astrazeneca vaccine to under 60-year-olds to be "understandable" - even if the vaccine itself is good and safe.
The SPD health expert Karl Lauterbach is also convinced of the effectiveness of the Astrazeneca vaccine.
"Of course I also took him," he wrote on Twitter and posted a picture showing his corona vaccination in the Leverkusen vaccination center with the Astrazeneca vaccine *.
(ph / dpa) * Merkur.de is an offer from IPPEN.MEDIA
List of rubric lists: © Matthias Bein